Hacker News Reader

I'm a bit suspicious of the hype + Ticker symbol. The Ticker Symbol for Spark Therapeutics is "ONCE". It is a $3bn valued company although is doesn't look like it has any revenue (around $1.5m) and has a huge deficit of -$74m (probably will be higher for the next year).

Seems like I have seen this movie before...

View on HN

Most biotechs don't have any revenue when they go public. They are traded on scientific progress through clinical trials. The idea being that if they do get through a phase 3, they are immediately valuable since they have a monopoly on a valuable therapeutic. Most likely, they get acquired by large pharma before that point - see Kite & Gilead.

Reply on news.ycombinator.com